The Case for PreEmptive Pharmacogenetic Screening in South Africa
dc.article.end-page | 14 | en |
dc.article.start-page | 1 | en |
dc.citation.doi | 10.3390/JPM14010114 | en |
dc.contributor.author | T Hurrell | en |
dc.contributor.author | J Naidoo | en |
dc.contributor.author | Collen Masimirembwa | en |
dc.contributor.author | Janine Scholefield | en |
dc.date.accessioned | 2024-10-08T11:20:02Z | |
dc.date.available | 2024-10-08T11:20:02Z | |
dc.department | SYDNEY BRENNER INSTITUTE FOR MOLECULAR BIOSCIENCE | en |
dc.faculty | FACULTY OF HEALTH SCIENCES | en |
dc.identifier.citation | WOS | en |
dc.identifier.issn | 2075-4426 | en |
dc.identifier.uri | https://hdl.handle.net/10539/41452 | |
dc.journal.title | The Case for PreEmptive Pharmacogenetic Screening in South Africa | en |
dc.journal.volume | 14 | en |
dc.title | The Case for PreEmptive Pharmacogenetic Screening in South Africa | en |
dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Journal Article.pdf
- Size:
- 559.44 KB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client